Young Lung Cancer Initiative Urges FDA to Restrict First-Line Immunotherapy for NSCLC Patients With ROS1 and RET Rearrangements
2026-07-17
PubComNonGov2026-07-17
Carter Struck
WASHINGTON, July 17 -- In response to a federal agency request for information, the following public comment letter was submitted electronically to the regulations.gov site.
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, July 17 -- In response to a federal agency request for information, the following public comment letter was submitted electronically to the regulations.gov site.
Comment to Docket . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026